Showing results (81-90 of 150) with videos related to
Sort By:
Pageof 15
Plos One|March 10, 2012
Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope proteinZhitao Ru, Wenjun Xiao, Anthony Pajot, et al.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|February 1, 2018
[Construction and identification of nanobody phage display library targeting Middle East respiratory syndrome coronavirus]Lei He, Jiangfan Li, Shuo Ren, et al.Molecular Therapy. Nucleic Acids|March 13, 2020
CRISPR-Cas13a Cleavage of Dengue Virus NS3 Gene Efficiently Inhibits Viral ReplicationHao Li, Shan Wang, Xue Dong, et al.Vaccine|September 22, 2014
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine designCuiqing Ma, Lili Wang, Xinrong Tao, et al.Human Vaccines & Immunotherapeutics|March 10, 2017
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infectionYufei Wang, Wanbo Tai, Jie Yang, et al.Vaccine|October 21, 2019
TFPR1 acts as an immune regulator and an efficient adjuvant for proteins and peptides by activating immune cells, primarily through TLR2Weilai Sun, Qiao Li, Xiuzhe Ning, et al.Plos One|April 12, 2017
Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cellsYang Zeng, Bingrun Liu, Marie-Thérèse Rubio, et al.Journal of Virology|December 11, 2012
Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutininLanying Du, Lei Jin, Guangyu Zhao, et al.Virology Journal|February 11, 2010
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitorChuanfu Zhang, Yuanyong Xu, Leili Jia, et al.International Immunopharmacology|April 6, 2018
C5a receptor1 inhibition alleviates influenza virus-induced acute lung injuryNianping Song, Pei Li, Yuting Jiang, et al.Pageof 15